Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000031

CEO bought 81,500 shares at an average $0.01 ($1,037)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

22 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-13 Purchase : show line 1 in the form +2,000 $0.01 $25 21,754,897 D
2019-05-13 Purchase : show line 2 in the form +50 $0.01 $1 21,754,947 D
2019-05-13 Purchase : show line 3 in the form +50 $0.01 $1 21,754,997 D
2019-05-13 Purchase : show line 4 in the form +4,900 $0.01 $61 21,759,897 D
2019-05-13 Purchase : show line 5 in the form +1,500 $0.01 $22 21,761,397 D
2019-05-14 Purchase : show line 6 in the form +15,000 $0.01 $179 21,776,397 D
2019-05-14 Purchase : show line 7 in the form +1,000 $0.01 $13 21,777,397 D
2019-05-14 Purchase : show line 8 in the form +2,000 $0.01 $27 21,779,397 D
Open-market purchases · 81,500 sh · avg $0.01 · $1,037
Loading xslF345X03/primary_doc.xml…